Skip to main content
McMaster University Menu Search

Platforms

Drug Discovery-icon

Drug Discovery

Drug screening is a powerful method for identifying new therapeutics for diseases. Our approach is to adapt human cells to a screening format so that we can find targeted therapeutics to combat cancer, neural disorders and metabolic disorders.

Principal Investigators

Mick Bhatia

Mick Bhatia

Director and Senior Scientist

Brad Doble

Brad Doble

Principal Investigator

Jon Draper

Jon Draper

Principal Investigator

Yu Lu

Yu Lu

Principal Investigator

Sheila Singh

Sheila Singh

Principal Investigator

Karun Singh

Karun Singh

Principal Investigator

Eva Szabo

Eva Szabo

Principal Investigator

Related Projects

To develop cell-based tools for use in drug screening of patient-specific stem cells.

To identify novel therapeutics that can target the bone marrow environment to destroy and prevent leukemia. By better understanding the optimal bone marrow conditions needed to support healthy blood stem cells, this study also has the potential to improve stem cell transplantation therapies.

The combination of standard of care chemotherapy, coupled with novel drugs discovered by our group, is hoped to prevent cancer relapse.

Related News

Hitting the Bullseye on Cancer Stem Cells

Hitting the Bullseye on Cancer Stem Cells

A team of researchers led by Dr. Mick Bhatia has identified a unique feature of cancer stem cells that can be exploited to kill the deadly cells thought to be the reason that cancer comes back after therapy. [...]

Paige Collins

Paige Collins | Thursday, June 22, 2017

Bhatia Lab Helps Human Cells Find Balance

Bhatia Lab Helps Human Cells Find Balance

In a study published today in Cell Reports, the Bhatia lab describes how they uncovered a solution to a major roadblock in unlocking the potential of hPSCs. [...]

Paige Collins

Paige Collins | Tuesday, April 4, 2017

Good Cells Grow In Ontario

Good Cells Grow In Ontario

To spotlight the province’s excellence in regenerative medicine and our capacity for commercialization, the Ontario Investment Office organized a tour for members of the international media. [...]

Paige Collins

Paige Collins | Wednesday, March 8, 2017